-
1
-
-
0038101450
-
Haemophilias A and B
-
Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet 361(9371), 1801-1809 (2003).
-
(2003)
Lancet
, vol.361
, Issue.9371
, pp. 1801-1809
-
-
Bolton-Maggs, P.H.1
Pasi, K.J.2
-
2
-
-
0021750055
-
Characterization of the human factor VIII gene
-
Gitschier J, Wood WI, Goralka TM et al. Characterization of the human factor VIII gene. Nature 312(5992), 326-330 (1984).
-
(1984)
Nature
, vol.312
, Issue.5992
, pp. 326-330
-
-
Gitschier, J.1
Wood, W.I.2
Goralka, T.M.3
-
3
-
-
0021715169
-
Molecular cloning of a cDNA encoding human antihaemophilic factor
-
Toole JJ, Knopf JL, Wozney JM et al. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 312(5992), 342-347 (1984).
-
(1984)
Nature
, vol.312
, Issue.5992
, pp. 342-347
-
-
Toole, J.J.1
Knopf, J.L.2
Wozney, J.M.3
-
4
-
-
1942521325
-
Bioengineering of coagulation factor VIII for improved secretion
-
Miao HZ, Sirachainan N, Palmer L et al. Bioengineering of coagulation factor VIII for improved secretion. Blood 103(9), 3412-3419 (2004).
-
(2004)
Blood
, vol.103
, Issue.9
, pp. 3412-3419
-
-
Miao, H.Z.1
Sirachainan, N.2
Palmer, L.3
-
5
-
-
0020582124
-
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus
-
Mann R, Mulligan RC, Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33(1), 153-159 (1983).
-
(1983)
Cell
, vol.33
, Issue.1
, pp. 153-159
-
-
Mann, R.1
Mulligan, R.C.2
Baltimore, D.3
-
6
-
-
0025257348
-
Retroviralmediated transfer and amplification of a functional human factor VIII gene
-
Israel DI, Kaufman RJ. Retroviralmediated transfer and amplification of a functional human factor VIII gene. Blood 75(5), 1074-1080 (1990).
-
(1990)
Blood
, vol.75
, Issue.5
, pp. 1074-1080
-
-
Israel, D.I.1
Kaufman, R.J.2
-
7
-
-
0034724857
-
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
-
DOI 10.1126/science.288.5466.669
-
Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288(5466), 669-672 (2000). (Pubitemid 30241569)
-
(2000)
Science
, vol.288
, Issue.5466
, pp. 669-672
-
-
Cavazzana-Calvo, M.1
Hacein-Bey, S.2
De Saint Basile, G.3
Gross, F.4
Yvon, E.5
Nusbaum, P.6
Selz, F.7
Hue, C.8
Certain, S.9
Casanova, J.-L.10
Bousso, P.11
Le Deist, F.12
Fischer, A.13
-
8
-
-
0142084745
-
LMO2-associated clonal T-cell proliferation in two patients after gene therapy for SCID-X1
-
Hacein-Bey-Abina S, Von Kalle C, Schmidt M et al. LMO2-associated clonal T-cell proliferation in two patients after gene therapy for SCID-X1. Science 302(5644), 415-419 (2003).
-
(2003)
Science
, vol.302
, Issue.5644
, pp. 415-419
-
-
Hacein-Bey-Abina, S.1
Von Kalle, C.2
Schmidt, M.3
-
9
-
-
51349158298
-
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
-
Howe SJ, Mansour MR, Schwarzwaelder K et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118(9), 3143-3150 (2008).
-
(2008)
J. Clin. Invest.
, vol.118
, Issue.9
, pp. 3143-3150
-
-
Howe, S.J.1
Mansour, M.R.2
Schwarzwaelder, K.3
-
10
-
-
0028842288
-
Gene therapy for hemophilia A: Production of therapeutic levels of human factor VIII in vivo in mice
-
Dwarki VJ, Belloni P, Nijjar T et al. Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice. Proc. Natl Acad. Sci. USA 92(4), 1023-1027 (1995).
-
(1995)
Proc. Natl Acad. Sci. USA
, vol.92
, Issue.4
, pp. 1023-1027
-
-
Dwarki, V.J.1
Belloni, P.2
Nijjar, T.3
-
11
-
-
0032510756
-
Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A
-
Evans GL, Morgan RA. Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A. Proc Natl Acad. Sci. USA, 95(10), 5734-5739 (1998).
-
(1998)
Proc Natl Acad. Sci. USA
, vol.95
, Issue.10
, pp. 5734-5739
-
-
Evans, G.L.1
Morgan, R.A.2
-
12
-
-
0026534020
-
Toward gene therapy in haemophilia A: Retrovirus-mediated transfer of a factor VIII gene into murine haematopoietic progenitor cells
-
Hoeben RC, Einerhand MP, Briet E, van Ormondt H, Valerio D, Van Der Eb AJ. Toward gene therapy in haemophilia A: retrovirus-mediated transfer of a factor VIII gene into murine haematopoietic progenitor cells. Thromb. Haemost. 67(3), 341-345 (1992).
-
(1992)
Thromb. Haemost.
, vol.67
, Issue.3
, pp. 341-345
-
-
Hoeben, R.C.1
Einerhand, M.P.2
Briet, E.3
Van Ormondt, H.4
Valerio, D.5
Van Der Eb, A.J.6
-
13
-
-
0141962306
-
Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction
-
Tiede A, Eder M, von Depka M et al. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction. Gene Ther. 10(22), 1917-1925 (2003).
-
(2003)
Gene Ther.
, vol.10
, Issue.22
, pp. 1917-1925
-
-
Tiede, A.1
Eder, M.2
Von Depka, M.3
-
14
-
-
0036330685
-
Generation and characterization of human hematopoietic cell lines expressing factor VIII. J. Hematother
-
Tonn T, Herder C, Becker S, Seifried E, Grez M. Generation and characterization of human hematopoietic cell lines expressing factor VIII. J. Hematother. Stem Cell Res. 11(4), 695-704 (2002).
-
(2002)
Stem Cell Res.
, vol.11
, Issue.4
, pp. 695-704
-
-
Tonn, T.1
Herder, C.2
Becker, S.3
Seifried, E.4
Grez, M.5
-
15
-
-
0034689505
-
Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice
-
Chuah MK, Van Damme A, Zwinnen H et al. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice. Hum. Gene Ther. 11(5), 729-738 (2000).
-
(2000)
Hum. Gene Ther.
, vol.11
, Issue.5
, pp. 729-738
-
-
Chuah, M.K.1
Van Damme, A.2
Zwinnen, H.3
-
16
-
-
0032080179
-
Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy
-
Connelly S, Andrews JL, Gallo AM et al. Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy. Blood 91(9), 3273-3281 (1998).
-
(1998)
Blood
, vol.91
, Issue.9
, pp. 3273-3281
-
-
Connelly, S.1
Andrews, J.L.2
Gallo, A.M.3
-
17
-
-
0029943193
-
Sustained expression of therapeutic levels of human factor VIII in mice
-
Connelly S, Gardner JM, Lyons RM, McClelland A, Kaleko M. Sustained expression of therapeutic levels of human factor VIII in mice. Blood 87(11), 4671-4677 (1996). (Pubitemid 26162366)
-
(1996)
Blood
, vol.87
, Issue.11
, pp. 4671-4677
-
-
Connelly, S.1
Gardner, J.M.2
Lyons, R.M.3
McClelland, A.4
Kaleko, M.5
-
18
-
-
0030069229
-
High-level tissue-specific expression of functional human factor VIII in mice
-
Connelly S, Gardner JM, McClelland A, Kaleko M. High-level tissue-specific expression of functional human factor VIII in mice. Hum. Gene Ther. %20;7(2), 183-195 (1996). (Pubitemid 26044837)
-
(1996)
Human Gene Therapy
, vol.7
, Issue.2
, pp. 183-195
-
-
Connelly, S.1
Gardner, J.M.2
McClelland, A.3
Kaleko, M.4
-
19
-
-
0028991820
-
In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice
-
Connelly S, Smith TA, Dhir G et al. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice. Hum. Gene Ther. 6(2), 185-193 (1995).
-
(1995)
Hum. Gene Ther.
, vol.6
, Issue.2
, pp. 185-193
-
-
Connelly, S.1
Smith, T.A.2
Dhir, G.3
-
20
-
-
0033587552
-
In vivo evaluation of an adenoviral vector encoding canine factor VIII: High-level, sustained expression in hemophiliac mice
-
Gallo-Penn AM, Shirley PS, Andrews JL et al. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice. Hum. Gene Ther. 10(11), 1791 - 1802 (1999).
-
(1999)
Hum. Gene Ther.
, vol.10
, Issue.11
, pp. 1791-1802
-
-
Gallo-Penn, A.M.1
Shirley, P.S.2
Andrews, J.L.3
-
21
-
-
0035174331
-
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs
-
Gallo-Penn AM, Shirley PS, Andrews JL et al. Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs. Blood 97(1), 107-113 (2001).
-
(2001)
Blood
, vol.97
, Issue.1
, pp. 107-113
-
-
Gallo-Penn, A.M.1
Shirley, P.S.2
Andrews, J.L.3
-
22
-
-
0036377825
-
Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vector
-
Andrews JL, Shirley PS, Iverson WO et al. Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vector. Hum. Gene Ther. 13(11), 1331-1336 (2002).
-
(2002)
Hum. Gene Ther.
, vol.13
, Issue.11
, pp. 1331-1336
-
-
Andrews, J.L.1
Shirley, P.S.2
Iverson, W.O.3
-
23
-
-
0033544952
-
Adenoviral vector-mediated expression of physiologic levels of human factor VIII in nonhuman primates
-
Brann T, Kayda D, Lyons RM et al. Adenoviral vector-mediated expression of physiologic levels of human factor VIII in nonhuman primates. Hum. Gene Ther. 10(18), 2999-3011 (1999).
-
(1999)
Hum. Gene Ther.
, vol.10
, Issue.18
, pp. 2999-3011
-
-
Brann, T.1
Kayda, D.2
Lyons, R.M.3
-
24
-
-
0029943155
-
A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and b-galactosidase
-
Kochanek S, Clemens PR, Mitani K, Chen HH, Chan S, Caskey CT. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and b-galactosidase. Proc. Natl Acad. Sci. USA 93(12), 5731-5736 (1996).
-
(1996)
Proc. Natl Acad. Sci. USA
, vol.93
, Issue.12
, pp. 5731-5736
-
-
Kochanek, S.1
Clemens, P.R.2
Mitani, K.3
Chen, H.H.4
Chan, S.5
Caskey, C.T.6
-
25
-
-
0031916435
-
Genomic DNA transfer with a highcapacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
-
Schiedner G, Morral N, Parks RJ et al. Genomic DNA transfer with a highcapacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18(2), 180-183 (1998).
-
(1998)
Nat. Genet.
, vol.18
, Issue.2
, pp. 180-183
-
-
Schiedner, G.1
Morral, N.2
Parks, R.J.3
-
26
-
-
13044304200
-
Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons
-
Morral N, O'Neal W, Rice K et al. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl Acad. Sci. USA 96(22), 12816-12821 (1999).
-
(1999)
Proc. Natl Acad. Sci. USA
, vol.96
, Issue.22
, pp. 12816-12821
-
-
Morral, N.1
O'Neal, W.2
Rice, K.3
-
27
-
-
0037372398
-
Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors
-
Chuah MK, Schiedner G, Thorrez L et al. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors. Blood 101(5), 1734-1743 (2003).
-
(2003)
Blood
, vol.101
, Issue.5
, pp. 1734-1743
-
-
Chuah, M.K.1
Schiedner, G.2
Thorrez, L.3
-
28
-
-
0036154968
-
Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector
-
Reddy PS, Sakhuja K, Ganesh S et al. Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector. Mol. Ther. 5(1), 63-73 (2002).
-
(2002)
Mol. Ther.
, vol.5
, Issue.1
, pp. 63-73
-
-
Reddy, P.S.1
Sakhuja, K.2
Ganesh, S.3
-
29
-
-
12944317288
-
Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector
-
Balague C, Zhou J, Dai Y et al. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood 95(3), 820-828 (2000).
-
(2000)
Blood
, vol.95
, Issue.3
, pp. 820-828
-
-
Balague, C.1
Zhou, J.2
Dai, Y.3
-
30
-
-
0032718034
-
Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A
-
Zhang WW, Josephs SF, Zhou J et al. Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A. Thromb. Haemost. 82(2), 562-571 (1999).
-
(1999)
Thromb. Haemost.
, vol.82
, Issue.2
, pp. 562-571
-
-
Zhang, W.W.1
Josephs, S.F.2
Zhou, J.3
-
31
-
-
2342461788
-
Preclinical gene therapy studies for hemophilia using adenoviral vectors
-
Thorrez L, Vanden Driessche T, Collen D, Chuah MK. Preclinical gene therapy studies for hemophilia using adenoviral vectors. Semin. Thromb. Hemost. 30(2), 173-183 (2004).
-
(2004)
Semin. Thromb. Hemost.
, vol.30
, Issue.2
, pp. 173-183
-
-
Thorrez, L.1
Vanden Driessche, T.2
Collen, D.3
Chuah, M.K.4
-
32
-
-
0035822005
-
Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A
-
Roth DA, Tawa NE Jr, O'Brien JM, Treco DA, Selden RF. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N. Engl. J. Med. 344(23), 1735-1742 (2001).
-
(2001)
N. Engl. J. Med.
, vol.344
, Issue.23
, pp. 1735-1742
-
-
Roth, D.A.1
Tawa Jr., N.E.2
O'Brien, J.M.3
Treco, D.A.4
Selden, R.F.5
-
33
-
-
0141679053
-
Phase 1 trial of fVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion
-
Powell JS, Ragni MV, White GC 2nd et al. Phase 1 trial of fVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion. Blood 102(6), 2038-2045 (2003).
-
(2003)
Blood
, vol.102
, Issue.6
, pp. 2038-2045
-
-
Powell, J.S.1
Ragni, M.V.2
White II, G.C.3
-
34
-
-
0032725333
-
Animal testing of retroviral-mediated gene therapy for factor VIII deficiency
-
Greengard JS, Jolly DJ. Animal testing of retroviral-mediated gene therapy for factor VIII deficiency. Thromb. Haemost. 82(2), 555-561 (1999).
-
(1999)
Thromb. Haemost.
, vol.82
, Issue.2
, pp. 555-561
-
-
Greengard, J.S.1
Jolly, D.J.2
-
35
-
-
0031424112
-
Biosynthesis, assembly and secretion of coagulation factor VIII
-
Kaufman RJ, Pipe SW, Tagliavacca L, Swaroop M, Moussalli M. Biosynthesis, assembly and secretion of coagulation factor VIII. Blood Coagul. Fibrinolysis 8(Suppl. 2), S3-S14 (1997).
-
(1997)
Blood Coagul. Fibrinolysis
, vol.8
, Issue.SUPPL. 2
-
-
Kaufman, R.J.1
Pipe, S.W.2
Tagliavacca, L.3
Swaroop, M.4
Moussalli, M.5
-
36
-
-
0028917478
-
Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region
-
Hoeben RC, Fallaux FJ, Cramer SJ et al. Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region. Blood 85(9), 2447-2454 (1995).
-
(1995)
Blood
, vol.85
, Issue.9
, pp. 2447-2454
-
-
Hoeben, R.C.1
Fallaux, F.J.2
Cramer, S.J.3
-
37
-
-
0029098922
-
Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation
-
Koeberl DD, Halbert CL, Krumm A, Miller AD. Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation. Hum. Gene Ther. 6(4), 469-479 (1995).
-
(1995)
Hum. Gene Ther.
, vol.6
, Issue.4
, pp. 469-479
-
-
Koeberl, D.D.1
Halbert, C.L.2
Krumm, A.3
Miller, A.D.4
-
38
-
-
0032478644
-
Differential interaction of coagulation factor VIII and factor v with protein chaperones calnexin and calreticulin
-
Pipe SW, Morris JA, Shah J, Kaufman RJ. Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin. J. Biol. Chem. 273(14), 8537-8544 (1998).
-
(1998)
J. Biol. Chem.
, vol.273
, Issue.14
, pp. 8537-8544
-
-
Pipe, S.W.1
Morris, J.A.2
Shah, J.3
Kaufman, R.J.4
-
39
-
-
0023597393
-
The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins
-
Dorner AJ, Bole DG, Kaufman RJ. The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins. J. Cell Biol. 105(6 Pt 1), 2665-2674 (1987).
-
(1987)
J. Cell Biol.
, vol.105
, Issue.6 PART 1
, pp. 2665-2674
-
-
Dorner, A.J.1
Bole, D.G.2
Kaufman, R.J.3
-
40
-
-
0035871099
-
The interaction of the calcium- and integrin-binding protein (cibp) with the coagulation factor VIII
-
Fang X, Chen C, Wang Q, Gu J, Chi C. The interaction of the calcium- and integrin-binding protein (cibp) with the coagulation factor VIII. Thromb. Res. 102(2), 177-185 (2001).
-
(2001)
Thromb. Res.
, vol.102
, Issue.2
, pp. 177-185
-
-
Fang, X.1
Chen, C.2
Wang, Q.3
Gu, J.4
Chi, C.5
-
41
-
-
0037336295
-
Quality control in the endoplasmic reticulum
-
Ellgaard L, Helenius A. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell. Biol. 4(3), 181-191 (2003).
-
(2003)
Nat. Rev. Mol. Cell. Biol.
, vol.4
, Issue.3
, pp. 181-191
-
-
Ellgaard, L.1
Helenius, A.2
-
42
-
-
0020595853
-
Hepatoma secretory proteins migrate from rough endoplasmic reticulum to Golgi at characteristic rates
-
Lodish HF, Kong N, Snider M, Strous GJ. Hepatoma secretory proteins migrate from rough endoplasmic reticulum to Golgi at characteristic rates. Nature 304(5921), 80-83 (1983).
-
(1983)
Nature
, vol.304
, Issue.5921
, pp. 80-83
-
-
Lodish, H.F.1
Kong, N.2
Snider, M.3
Strous, G.J.4
-
43
-
-
0032478548
-
Mutations in the ER-golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors v and VIII
-
Nichols WC, Seligsohn U, Zivelin A et al. Mutations in the ER-golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 93(1), 61-70 (1998).
-
(1998)
Cell
, vol.93
, Issue.1
, pp. 61-70
-
-
Nichols, W.C.1
Seligsohn, U.2
Zivelin, A.3
-
44
-
-
0038278822
-
Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex
-
Zhang B, Cunningham MA, Nichols WC et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat. Genet. 34(2), 220-225 (2003).
-
(2003)
Nat. Genet.
, vol.34
, Issue.2
, pp. 220-225
-
-
Zhang, B.1
Cunningham, M.A.2
Nichols, W.C.3
-
45
-
-
0032704952
-
Mannosedependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53- mediated ER to Golgi trafficking of coagulation factors v and VIII
-
Moussalli M, Pipe SW, Hauri HP, Nichols WC, Ginsburg D, Kaufman RJ. Mannosedependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53- mediated ER to Golgi trafficking of coagulation factors V and VIII. J. Biol. Chem. 274(46), 32539-32542 (1999).
-
(1999)
J. Biol. Chem.
, vol.274
, Issue.46
, pp. 32539-32542
-
-
Moussalli, M.1
Pipe, S.W.2
Hauri, H.P.3
Nichols, W.C.4
Ginsburg, D.5
Kaufman, R.J.6
-
46
-
-
1942430638
-
LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII
-
Cunningham MA, Pipe SW, Zhang B et al. LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII. J. Thromb. Haemost. 1(11), 2360-2367 (2003).
-
(2003)
J. Thromb. Haemost.
, vol.1
, Issue.11
, pp. 2360-2367
-
-
Cunningham, M.A.1
Pipe, S.W.2
Zhang, B.3
-
47
-
-
3543036376
-
Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells
-
Becker S, Simpson JC, Pepperkok R et al. Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells. Thromb. Haemost. 92(1), 23-35 (2004).
-
(2004)
Thromb. Haemost.
, vol.92
, Issue.1
, pp. 23-35
-
-
Becker, S.1
Simpson, J.C.2
Pepperkok, R.3
-
48
-
-
0022909287
-
Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule
-
Eaton DL, Wood WI, Eaton D et al. Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry 25(26), 8343-8347 (1986).
-
(1986)
Biochemistry
, vol.25
, Issue.26
, pp. 8343-8347
-
-
Eaton, D.L.1
Wood, W.I.2
Eaton, D.3
-
49
-
-
0022760260
-
A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity
-
Toole JJ, Pittman DD, Orr EC, Murtha P, Wasley LC, Kaufman RJ. A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. Proc. Natl Acad. Sci. USA 83(16), 5939-5942 (1986).
-
(1986)
Proc. Natl Acad. Sci. USA
, vol.83
, Issue.16
, pp. 5939-5942
-
-
Toole, J.J.1
Pittman, D.D.2
Orr, E.C.3
Murtha, P.4
Wasley, L.C.5
Kaufman, R.J.6
-
50
-
-
0027319588
-
Biochemical, immunological, and in vivo functional characterization of B-domaindeleted factor VIII
-
Pittman DD, Alderman EM, Tomkinson KN, Wang JH, Giles AR, Kaufman RJ. Biochemical, immunological, and in vivo functional characterization of B-domaindeleted factor VIII. Blood 81(11), 2925-2935 (1993).
-
(1993)
Blood
, vol.81
, Issue.11
, pp. 2925-2935
-
-
Pittman, D.D.1
Alderman, E.M.2
Tomkinson, K.N.3
Wang, J.H.4
Giles, A.R.5
Kaufman, R.J.6
-
51
-
-
0034905074
-
A factor VIII minigene comprising the truncated intron i of factor IX highly improves the in vitro production of factor VIII
-
Plantier JL, Rodriguez MH, Enjolras N, Attali O, Negrier C. A factor VIII minigene comprising the truncated intron I of factor IX highly improves the in vitro production of factor VIII. Thromb. Haemost. 86(2), 596-603 (2001).
-
(2001)
Thromb. Haemost.
, vol.86
, Issue.2
, pp. 596-603
-
-
Plantier, J.L.1
Rodriguez, M.H.2
Enjolras, N.3
Attali, O.4
Negrier, C.5
-
52
-
-
0030821993
-
Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII
-
Swaroop M, Moussalli M, Pipe SW, Kaufman RJ. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII. J. Biol. Chem. 272(39), 24121-24124 (1997).
-
(1997)
J. Biol. Chem.
, vol.272
, Issue.39
, pp. 24121-24124
-
-
Swaroop, M.1
Moussalli, M.2
Pipe, S.W.3
Kaufman, R.J.4
-
53
-
-
0037064064
-
High level expression of recombinant porcine coagulation factor VIII
-
DOI 10.1074/jbc.M206959200
-
Doering CB, Healey JF, Parker ET, Barrow RT, Lollar P. High level expression of recombinant porcine coagulation factor VIII. J. Biol. Chem. 277(41), 38345-38349 (2002). (Pubitemid 35154689)
-
(2002)
Journal of Biological Chemistry
, vol.277
, Issue.41
, pp. 38345-38349
-
-
Doering, C.B.1
Healey, J.F.2
Parker, E.T.3
Barrow, R.T.4
Lollar, P.5
-
54
-
-
1342282981
-
Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion
-
Doering CB, Healey JF, Parker ET, Barrow RT, Lollar P. Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion. J. Biol. Chem. 279(8), 6546-6552 (2004).
-
(2004)
J. Biol. Chem.
, vol.279
, Issue.8
, pp. 6546-6552
-
-
Doering, C.B.1
Healey, J.F.2
Parker, E.T.3
Barrow, R.T.4
Lollar, P.5
-
55
-
-
0033505104
-
Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: Sustained response in two of four patients
-
Burt RK, Georganas C, Schroeder J et al. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis Rheum. 42(11), 2281-2285 (1999).
-
(1999)
Arthritis Rheum.
, vol.42
, Issue.11
, pp. 2281-2285
-
-
Burt, R.K.1
Georganas, C.2
Schroeder, J.3
-
56
-
-
0037372443
-
High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn's disease
-
Burt RK, Traynor A, Oyama Y, Craig R. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn's disease. Blood 101(5), 2064-2066 (2003).
-
(2003)
Blood
, vol.101
, Issue.5
, pp. 2064-2066
-
-
Burt, R.K.1
Traynor, A.2
Oyama, Y.3
Craig, R.4
-
57
-
-
0030667512
-
Hematopoietic stem-cell transplantation for systemic lupus erythematosus
-
Burt RK, Traynor A, Ramsey-Goldman R. Hematopoietic stem-cell transplantation for systemic lupus erythematosus. N. Engl. J. Med. 337(24), 1777-1778 (1997).
-
(1997)
N. Engl. J. Med.
, vol.337
, Issue.24
, pp. 1777-1778
-
-
Burt, R.K.1
Traynor, A.2
Ramsey-Goldman, R.3
-
58
-
-
32044473487
-
Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus
-
Burt RK, Traynor A, Statkute L et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295(5), 527-535 (2006).
-
(2006)
JAMA
, vol.295
, Issue.5
, pp. 527-535
-
-
Burt, R.K.1
Traynor, A.2
Statkute, L.3
-
59
-
-
0031907910
-
T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: Report on the first three patients
-
Burt RK, Traynor AE, Cohen B et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant. 21(6), 537-541 (1998).
-
(1998)
Bone Marrow Transplant.
, vol.21
, Issue.6
, pp. 537-541
-
-
Burt, R.K.1
Traynor, A.E.2
Cohen, B.3
-
60
-
-
33646585786
-
High-level expression of porcine factor VIII from genetically modified bone marrow-derived stem cells
-
Gangadharan B, Parker ET, Ide LM, Spencer HT, Doering CB. High-level expression of porcine factor VIII from genetically modified bone marrow-derived stem cells. Blood 107(10), 3859-3864 (2006).
-
(2006)
Blood
, vol.107
, Issue.10
, pp. 3859-3864
-
-
Gangadharan, B.1
Parker, E.T.2
Ide, L.M.3
Spencer, H.T.4
Doering, C.B.5
-
61
-
-
34249737517
-
Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity
-
Doering CB, Gangadharan B, Dukart HZ, Spencer HT. Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity. Mol. Ther. 15(6), 1093-1099 (2007).
-
(2007)
Mol. Ther.
, vol.15
, Issue.6
, pp. 1093-1099
-
-
Doering, C.B.1
Gangadharan, B.2
Dukart, H.Z.3
Spencer, H.T.4
-
62
-
-
35349015845
-
Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens
-
Ide LM, Gangadharan B, Chiang KY, Doering CB, Spencer HT. Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens. Blood 110(8), 2855-2863 (2007).
-
(2007)
Blood
, vol.110
, Issue.8
, pp. 2855-2863
-
-
Ide, L.M.1
Gangadharan, B.2
Chiang, K.Y.3
Doering, C.B.4
Spencer, H.T.5
-
63
-
-
7044284791
-
Sustained phenotypic correction of hemophilia A mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells
-
Moayeri M, Ramezani A, Morgan RA, Hawley TS, Hawley RG. Sustained phenotypic correction of hemophilia A mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells. Mol. Ther. 10(5), 892-902 (2004).
-
(2004)
Mol. Ther.
, vol.10
, Issue.5
, pp. 892-902
-
-
Moayeri, M.1
Ramezani, A.2
Morgan, R.A.3
Hawley, T.S.4
Hawley, R.G.5
-
64
-
-
0037097841
-
Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy
-
DOI 10.1182/blood.V99.12.4394
-
Bagley J, Tian C, Sachs DH, Iacomini J. Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy. Blood 99(12), 4394-4399 (2002). (Pubitemid 34627206)
-
(2002)
Blood
, vol.99
, Issue.12
, pp. 4394-4399
-
-
Bagley, J.1
Tian, C.2
Sachs, D.H.3
Lacomini, J.4
-
65
-
-
28844477590
-
Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE
-
Xu B, Haviernik P, Wolfraim LA, Bunting KD, Scott DW. Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE. Mol. Ther. 13(1), 42-48 (2006).
-
(2006)
Mol. Ther.
, vol.13
, Issue.1
, pp. 42-48
-
-
Xu, B.1
Haviernik, P.2
Wolfraim, L.A.3
Bunting, K.D.4
Scott, D.W.5
-
66
-
-
0034330694
-
Induction of B-cell tolerance by retroviral gene therapy
-
Bracy JL, Iacomini J. Induction of B-cell tolerance by retroviral gene therapy. Blood 96(9), 3008-3015 (2000).
-
(2000)
Blood
, vol.96
, Issue.9
, pp. 3008-3015
-
-
Bracy, J.L.1
Iacomini, J.2
-
67
-
-
28444459497
-
Correction of murine hemophilia A by hematopoietic stem cell gene therapy
-
Moayeri M, Hawley TS, Hawley RG. Correction of murine hemophilia A by hematopoietic stem cell gene therapy. Mol. Ther. 12(6), 1034-1042 (2005).
-
(2005)
Mol. Ther.
, vol.12
, Issue.6
, pp. 1034-1042
-
-
Moayeri, M.1
Hawley, T.S.2
Hawley, R.G.3
-
68
-
-
67649840877
-
Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A
-
Doering CB, Denning G, Dooriss K et al. Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A. Mol. Ther. 17(7), 1145-1154 (2009).
-
(2009)
Mol. Ther.
, vol.17
, Issue.7
, pp. 1145-1154
-
-
Doering, C.B.1
Denning, G.2
Dooriss, K.3
-
69
-
-
73349111285
-
Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy
-
Peng B, Ye P, Rawlings DJ, Ochs HD, Miao CH. Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy. Blood 114, 4373-4382 (2009).
-
(2009)
Blood
, vol.114
, pp. 4373-4382
-
-
Peng, B.1
Ye, P.2
Rawlings, D.J.3
Ochs, H.D.4
Miao, C.H.5
-
70
-
-
52649172605
-
Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice
-
Peng B, Ye P, Blazar BR et al. Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice. Blood 112(5), 1662-1672 (2008).
-
(2008)
Blood
, vol.112
, Issue.5
, pp. 1662-1672
-
-
Peng, B.1
Ye, P.2
Blazar, B.R.3
-
71
-
-
77950384133
-
CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy treated hemophilia mice
-
Miao CH, Harmeling BR, Ziegler SF et al. CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy treated hemophilia mice. Blood 114(19), 4034-4044 (2009).
-
(2009)
Blood
, vol.114
, Issue.19
, pp. 4034-4044
-
-
Miao, C.H.1
Harmeling, B.R.2
Ziegler, S.F.3
-
72
-
-
70149086119
-
A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cells
-
Matsui H, Shibata M, Brown B et al. A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cells. Blood 114(3), 677-685 (2009).
-
(2009)
Blood
, vol.114
, Issue.3
, pp. 677-685
-
-
Matsui, H.1
Shibata, M.2
Brown, B.3
-
73
-
-
33845648448
-
Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Iba promoter: In vivo model for platelettargeting gene therapy
-
Ohmori T, Mimuro J, Takano K et al. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Iba promoter: in vivo model for platelettargeting gene therapy. FASEB J. 20(9), 1522-1524 (2006).
-
(2006)
FASEB J.
, vol.20
, Issue.9
, pp. 1522-1524
-
-
Ohmori, T.1
Mimuro, J.2
Takano, K.3
-
74
-
-
10744231807
-
Factor VIII ectopically expressed in platelets: Efficacy in hemophilia A treatment
-
Yarovoi HV, Kufrin D, Eslin DE et al. Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment. Blood 102(12), 4006-4013 (2003).
-
(2003)
Blood
, vol.102
, Issue.12
, pp. 4006-4013
-
-
Yarovoi, H.V.1
Kufrin, D.2
Eslin, D.E.3
-
75
-
-
20444417088
-
Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: Lessons from platelet-expressed factor VIII
-
Yarovoi H, Nurden AT, Montgomery RR, Nurden P, Poncz M. Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIII. Blood 105(12), 4674-4676 (2005).
-
(2005)
Blood
, vol.105
, Issue.12
, pp. 4674-4676
-
-
Yarovoi, H.1
Nurden, A.T.2
Montgomery, R.R.3
Nurden, P.4
Poncz, M.5
-
76
-
-
33745864802
-
Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
-
Shi Q, Wilcox DA, Fahs SA et al. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. J. Clin. Invest. 116(7), 1974-1982 (2006).
-
(2006)
J. Clin. Invest.
, vol.116
, Issue.7
, pp. 1974-1982
-
-
Shi, Q.1
Wilcox, D.A.2
Fahs, S.A.3
-
77
-
-
45549109031
-
Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors
-
Gewirtz J, Thornton MA, Rauova L, Poncz M. Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors. J. Thromb. Haemost. 6(7), 1160-1166 (2008).
-
(2008)
J. Thromb. Haemost.
, vol.6
, Issue.7
, pp. 1160-1166
-
-
Gewirtz, J.1
Thornton, M.A.2
Rauova, L.3
Poncz, M.4
-
78
-
-
44249085878
-
Safety and efficacy of gene transfer for Leber's congenital amaurosis
-
Maguire AM, Simonelli F, Pierce EA et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358(21), 2240-2248 (2008).
-
(2008)
N. Engl. J. Med.
, vol.358
, Issue.21
, pp. 2240-2248
-
-
Maguire, A.M.1
Simonelli, F.2
Pierce, E.A.3
-
79
-
-
44249120315
-
Effect of gene therapy on visual function in Leber's congenital amaurosis
-
Bainbridge JW, Smith AJ, Barker SS et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 358(21), 2231-2239 (2008).
-
(2008)
N. Engl. J. Med.
, vol.358
, Issue.21
, pp. 2231-2239
-
-
Bainbridge, J.W.1
Smith, A.J.2
Barker, S.S.3
-
80
-
-
20144386644
-
Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system
-
Ohlfest JR, Frandsen JL, Fritz S et al. Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system. Blood 105(7), 2691-2698 (2005).
-
(2005)
Blood
, vol.105
, Issue.7
, pp. 2691-2698
-
-
Ohlfest, J.R.1
Frandsen, J.L.2
Fritz, S.3
-
81
-
-
33645882508
-
Sustained fVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon
-
Liu L, Mah C, Fletcher BS. Sustained fVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon. Mol. Ther. 13(5), 1006-1015 (2006).
-
(2006)
Mol. Ther.
, vol.13
, Issue.5
, pp. 1006-1015
-
-
Liu, L.1
Mah, C.2
Fletcher, B.S.3
-
82
-
-
67349250885
-
Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates
-
Mates L, Chuah MK, Belay E et al. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat. Genet. 41(6), 753-761 (2009).
-
(2009)
Nat. Genet.
, vol.41
, Issue.6
, pp. 753-761
-
-
Mates, L.1
Chuah, M.K.2
Belay, E.3
-
83
-
-
68849130485
-
Nanocapsule-delivered Sleeping Beauty mediates therapeutic factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice
-
Kren BT, Unger GM, Sjeklocha L et al. Nanocapsule-delivered Sleeping Beauty mediates therapeutic factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice. J. Clin. Invest. 119(7), 2086-2099 (2009).
-
(2009)
J. Clin. Invest.
, vol.119
, Issue.7
, pp. 2086-2099
-
-
Kren, B.T.1
Unger, G.M.2
Sjeklocha, L.3
-
84
-
-
0033538448
-
Expression of factor VIII by murine liver sinusoidal endothelial cells
-
Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells. J. Biol. Chem. 274(28), 19587-19592 (1999).
-
(1999)
J. Biol. Chem.
, vol.274
, Issue.28
, pp. 19587-19592
-
-
Do, H.1
Healey, J.F.2
Waller, E.K.3
Lollar, P.4
-
85
-
-
0842264039
-
Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype
-
Sarkar R, Tetreault R, Gao G et al. Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype. Blood 103(4), 1253-1260 (2004).
-
(2004)
Blood
, vol.103
, Issue.4
, pp. 1253-1260
-
-
Sarkar, R.1
Tetreault, R.2
Gao, G.3
-
86
-
-
33645908797
-
Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia A dogs and mice
-
Sarkar R, Mucci M, Addya S et al. Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia A dogs and mice. Hum. Gene Ther. 17(4), 427-439 (2006).
-
(2006)
Hum. Gene Ther.
, vol.17
, Issue.4
, pp. 427-439
-
-
Sarkar, R.1
Mucci, M.2
Addya, S.3
-
87
-
-
33745606715
-
Multiyear therapeutic benefit of AAV serotypes 2, 6 and 8 delivering factor VIII to hemophilia A mice and dogs
-
Jiang H, Lillicrap D, Patarroyo-White S et al. Multiyear therapeutic benefit of AAV serotypes 2, 6 and 8 delivering factor VIII to hemophilia A mice and dogs. Blood 108(1), 107-115 (2006).
-
(2006)
Blood
, vol.108
, Issue.1
, pp. 107-115
-
-
Jiang, H.1
Lillicrap, D.2
Patarroyo-White, S.3
-
88
-
-
46249125272
-
Complete correction of hemophilia A with adenoassociated viral vectors containing a full-size expression cassette
-
Lu H, Chen L, Wang J et al. Complete correction of hemophilia A with adenoassociated viral vectors containing a full-size expression cassette. Hum. Gene Ther. 19(6), 648-654 (2008).
-
(2008)
Hum. Gene Ther.
, vol.19
, Issue.6
, pp. 648-654
-
-
Lu, H.1
Chen, L.2
Wang, J.3
-
89
-
-
61649128763
-
Enhanced factor VIII heavy chain for gene therapy of hemophilia A
-
Chen L, Lu H, Wang J et al. Enhanced factor VIII heavy chain for gene therapy of hemophilia A. Mol. Ther. 17(3), 417-424 (2009).
-
(2009)
Mol. Ther.
, vol.17
, Issue.3
, pp. 417-424
-
-
Chen, L.1
Lu, H.2
Wang, J.3
-
90
-
-
34548796475
-
The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene
-
Chen L, Zhu F, Li J et al. The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol. Ther. 15(10), 1856-1862 (2007).
-
(2007)
Mol. Ther.
, vol.15
, Issue.10
, pp. 1856-1862
-
-
Chen, L.1
Zhu, F.2
Li, J.3
-
91
-
-
59149093795
-
The treatment of hemophilia A: From protein replacement to AAV-mediated gene therapy
-
Youjin S, Jun Y. The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy. Biotechnol. Lett. 31(3), 321-328 (2009).
-
(2009)
Biotechnol. Lett.
, vol.31
, Issue.3
, pp. 321-328
-
-
Youjin, S.1
Jun, Y.2
-
92
-
-
35349027352
-
Immune responses to AAV in clinical trials
-
Mingozzi F, High KA. Immune responses to AAV in clinical trials. Curr. Gene Ther. 7(5), 316-324 (2007).
-
(2007)
Curr. Gene Ther.
, vol.7
, Issue.5
, pp. 316-324
-
-
Mingozzi, F.1
High, K.A.2
-
93
-
-
0037079740
-
Use of blood outgrowth endothelial cells for gene therapy for hemophilia A
-
Lin Y, Chang L, Solovey A, Healey JF, Lollar P, Hebbel RP. Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. Blood 99(2), 457-462 (2002).
-
(2002)
Blood
, vol.99
, Issue.2
, pp. 457-462
-
-
Lin, Y.1
Chang, L.2
Solovey, A.3
Healey, J.F.4
Lollar, P.5
Hebbel, R.P.6
-
94
-
-
35348867348
-
Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors
-
Matsui H, Shibata M, Brown B et al. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors. Stem Cells 25(10), 2660-2669 (2007).
-
(2007)
Stem Cells
, vol.25
, Issue.10
, pp. 2660-2669
-
-
Matsui, H.1
Shibata, M.2
Brown, B.3
-
95
-
-
63649133449
-
Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo
-
Wang J, Mansfield SG, Cote CA et al. Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo. Mol. Ther. 17(2), 343-351 (2009).
-
(2009)
Mol. Ther.
, vol.17
, Issue.2
, pp. 343-351
-
-
Wang, J.1
Mansfield, S.G.2
Cote, C.A.3
|